1. Home
  2. /
  3. Projects

IAVI

Home – IAVI

Advancing evidence-informed in-country decision-making for new TB vaccine introduction: A responsive and integrated vaccine modelling approach from India

hypothetical
Ongoing
As new TB vaccines move into late-stage development, it is imperative for high-burden countries like India to ensure timely and effective evidence-generation to inform decision-making and accelerate vaccine development and introduction. To enable this, an in-country vaccine mathematical modelling effort has been initiated in India.

IAVI

Ongoing
1. Understand likely use cases, delivery strategies, target populations, and drivers of preference and adoption; 2. Project demand; 3. Evaluate potential willingness to pay and budget impact; 4. Explore innovative financing mechanisms;

New tuberculosis vaccines are in late-stage trials, but how confident is the public in high burden countries in vaccines?

Ongoing
With tuberculosis (TB) vaccine candidates in late-stage trials, it is important to prepare for implementation to avoid delays upon licensure. General confidence in vaccines has been identified as an anticipated barrier to introducing new TB vaccines. In the absence of detailed TB specific vaccine acceptability and confidence data, we analysed currently available vaccine confidence data in countries appearing on one of the World Health Organization (WHO) high burden lists to investigate vaccine confidence in countries with a high TB burden

Forecasting TB vaccine demand to support supply and procurement planning

Ongoing
We present insights from two workshops with global health funders, academics, and in country TB and vaccine decision-makers and estimates of potential global demand for TB vaccines using a bottom-up, constrained demand forecasting model. The model was informed by the workshops, publicly available target product profile, landscape assessment of vaccines in development, information from proxy vaccines sourced from the WHO databases and peer reviewed literature, and interviews with TB and vaccine experts

Financing and policy innovation to advance TB vaccines through licensure: A G20 policy proposal

Ongoing
The authors developed two T20 policy briefs proposing recommendations to enhance G20 leadership and bring TB vaccines through licensure: Investment Toolbox to Advance TB Vaccine R&D through Joint Action (2023); and Elevating Leadership of HBC G20 States in TB Vaccine R&D and Delivery (2024). The briefs were informed by extensive literature research and aligned with global initiatives for TB and TB vaccine R&D.

Global TB vaccine partnership

2011-2023
Ongoing
The Global Tuberculosis Vaccine Partnership (GTBVP) is a forum for key stakeholders in TB vaccine R&D to identify and address barriers impeding TB vaccine R&D and to discuss R&D priorities in order to help inform funding decisions
Load More
Click to copy link of this header Menu